Eva Terras

Pediatric cancer is the most common cause of disease-related death in children. Cure rates have significantly improved over the last years, but therapy-related late effects are still a common problem. Our goal is to contribute to increase the cure rates of pediatric cancer and decrease the therapy-related late effects within survivors. We focus on various pediatric cancer types, like ALL, AML, JMML, MDS, LBL and NB.

My main task is to collect, process and store bone marrow, blood and liquid biopsies, taken in the context of clinical studies, to create an extensive biobank for pediatric cancer research. The samples are either residual material that remains after a diagnostic examination or material that is collected prospectively for use in research.

Secondary I contribute to several research projects arising from clinical studies or projects in collaboration with PhD students or other students, by performing nucleic acid and protein extractions, RT-qPCR, flowcytometry and other techniques related to our projects. 
 

I obtained a Bachelor in Medical Laboratory Technology (KaHo Sint-Lieven, 2010).
As of July 2010, I’m a cancer research technician at the Lab for Pediatric Hematology-Oncology.
I have experience in isolation of mononuclear cells from peripheral blood and bone marrow, nucleic acid extractions from tissues and body fluids, nucleic acid quality control, RT-qPCR, flowcytometry, cell culture. 
 

• ‘Deciphering Molecular Heterogeneity in Pediatric AML Using a Cancer versus Normal Transcriptomic Approach’. Pediatric Research, 2020. (PMID: 33069162)
   

• Lab address: Laboratory for Pediatric Hematology-Oncology and Stem Cell Transplantation, ingang 10 (route 1034), Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent
• Lab for Pediatric Hematology-Oncology
• LinkedIn    
• ORCID ID     
• Involved in Biobank of Pediatric Hematology-Oncology